Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine: A randomized, double-blind clinical trial

Spotswood L. Spruance, Andrew T. Pavia, Dolores Peterson, Allison Berry, Richard Pollard, Thomas F. Patterson, Ian Frank, Scot C. Remick, Melanie Thompson, Rodger D. MacArthur, G. E. Morey, Carlos H. Ramirez-Ronda, Barry M. Bernstein, Donna E. Sweet, Lawrence Crane, Eskild A. Peterson, Constance T. Pachucki, Stephen L. Green, Jerry Brand, Adan RiosLisa M. Dunkle, Anne Cross, Michael J. Brown, Peter Ingraham, Ronald Gugliotti, Andrew H. Schindzielorz, Laurie Smaldone

Producción científica: Articlerevisión exhaustiva

71 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine: A randomized, double-blind clinical trial'. En conjunto forman una huella única.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science